M

McKesson

Supplies medicines and technology to healthcare teams

Pharmacy Sales Consultant

Full-TimeUpdated
$132.9k - $221.5k+ Target incentive + Annual bonus + Long-term incentive opportunities
Mid
Bachelor's
New York, NY, USA
RemoteMust live in the assigned territory; ideally in the New York City area.
Sales & Account ManagementField Sales
No H1B Sponsorship

About the job

Requirements
  • Typically requires 4 or more years of relevant experience.
  • A bachelor's degree emphasizing sales, marketing, business management, or a healthcare-related field is preferred, or equivalent experience.
  • At least 4 years of sales experience with a track record of delivering results and meeting or exceeding sales goals.
  • At least 2 years of medical and/or pharmacy experience.
  • At least 4 years of business-to-business field sales experience.
  • Proficiency using a customer relationship management tool such as Salesforce or ACT.
  • Proficiency with Microsoft Office Suite, including Excel, PowerPoint, Word, and Outlook.
  • Use a consultative sales approach to identify customer needs.
  • Analysis, problem-solving, and negotiation skills.
  • Ability to articulate the organization's value proposition to customers.
  • Business and financial acumen.
  • Communicate persuasively, listen actively, and tailor messages to different audiences.
  • Be organized, accountable, assertive, and results-focused.
  • Must live in the assigned territory, ideally in the New York City area.
  • Must have a valid driver's license and a clean driving record/MVR.
  • Must be able to travel extensively overnight, 8–12 nights per month, and visit customers 80% of the time.
  • Must be authorized to work in the United States without restriction or need for current or future employer sponsorship.
Responsibilities
  • Achieve annual budget objectives for the assigned sales territory.
  • Build a comprehensive business plan to optimize short- and long-term territory performance.
  • Lead the consultative sales process from qualification through contract negotiations for opportunities in the assigned territory.
  • Build an opportunity funnel through organic prospecting, including cold calling, and coordinated efforts.
  • Contribute meaningfully to the future improvement and development of McKesson products and services by leveraging pharmacy partners' experience.
  • Provide customers with marketing advice, financial analysis to formulate financial plans, managed care information, competitive data, and profit-enhancing opportunities using sales methodologies and programs that demonstrate the benefits of company products, services, and technologies.
  • Develop sales proposals, business reviews, sales presentations, product and service demonstrations, merchandising plans, and sales promotions to grow existing business or capture new accounts.
  • Enhance relationships with key customers to build and maintain the credibility needed to retain business long term.
  • Provide problem-solving and troubleshooting expertise to customers while servicing existing accounts, collaborating with other departments.
  • Participate in sales team presentations where appropriate to support business growth opportunities, improve selling skills, and gain customer-base knowledge.
  • Maintain current, detailed, and accurate data in Salesforce.com CRM and provide accurate real-time sales forecasts.
  • Complete special projects as assigned.
Desired Qualifications
  • Experience in retail or distribution, healthcare delivery, pharmacy, community pharmacy, benefits, or insurance is helpful and preferred.

About the company

McKesson distributes medicines and medical supplies to pharmacies, hospitals and other care providers, alongside services that connect drug manufacturers with patients. Its specialty businesses support community cancer care and clinical research, extending its work beyond moving products through warehouses. The company buys drugs and supplies from manufacturers for resale, while its software helps pharmacies manage inventory and healthcare teams secure insurance approval for prescriptions. It also sells practice management and patient support services to clinicians and drugmakers. McKesson traces its business roots to 1833 and is headquartered in Irving, Texas.

Company Size

10,001+

Company Stage

IPO

Headquarters

Irving, Texas

Founded

1833

Get referred to McKesson

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Reinvestment has cash behind it: McKesson reported $6.2 billion operating cash flow for fiscal 2026 in May 2026.
  • Specialty expansion drives growth: McKesson reported 31% higher fiscal 2026 Oncology and Multispecialty sales in May 2026.
  • Technical candidates have openings: McKesson lists 154 information technology jobs on its career site in October 2026.

What critics are saying

  • One customer holds bargaining power: CVS generated 24% of McKesson's fiscal 2026 revenue, reported in May 2026.
  • Technology jobs face cuts: McKesson approved prescription technology headcount reductions during January through March 2026.
  • Medical supply careers face separation: McKesson outlined a planned Medical-Surgical IPO alongside Apollo's investment agreement in April 2026.

What makes McKesson unique

  • McKesson backs independent ownership: its Health Mart franchise supports pharmacies that remain independently owned and operated.
  • Generic purchasing has a retail partner: McKesson and Walmart jointly source medicines through ClarusONE.
  • McKesson reaches prescribing workflows: CoverMyMeds processes insurance approval requests free for clinicians across all plans and medications.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Performance Bonus
  • 401(k) Company Match

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Oct 29th, 2026
McKesson affirms $0.94 quarterly dividend ahead of November earnings

McKesson's board has affirmed a regular quarterly dividend of $0.94 per share, payable on January 4, 2027, to shareholders of record on December 1, 2026. The move comes ahead of the company's earnings report on November 4. Investors will watch whether cash flow can support both dividends and reinvestment in oncology and technology platforms such as CoverMyMeds and RxTS. Key risks include drug pricing scrutiny, costs tied to the recent cyber incident, and weaker GLP-1 access volumes. Analyst assumptions project revenue of $500.5 billion and earnings of $6.4 billion by 2029, based on 6.8% yearly revenue growth. Earnings today stand at $4.6 billion.

Yahoo Finance
Oct 23rd, 2026
Fastenal and McKesson are cash-rich stocks to buy this week; Carlisle is one to avoid

StockStory has named two cash-producing stocks to buy this week and one to avoid, saying cash generation alone doesn't make a company a winner. The stock to avoid is Carlisle (NYSE:CSL), a construction materials and weatherproofing maker with a 17% trailing 12-month free cash flow margin. StockStory cites weak organic revenue growth, projected sales growth of 5.8%, and annual earnings per share growth of just 3.6% over two years. Shares trade at $352.84, or 15.1x forward earnings. Fastenal (NASDAQ:FAST), with a 13% free cash flow margin, has a 45.3% gross margin, a 20.5% operating margin, and a 32.3% return on capital. Its shares trade at $52.32, or 38x forward earnings. McKesson (NYSE:MCK) has a 1.5% margin. Sales grew 14.5% annually over two years, and revenue reached $411 billion. Shares trade at $1,010, or 21.8x forward earnings.

AD HOC NEWS
Oct 15th, 2026
McKesson commits $1.4B for 49% stake in Option Care at $5.8B valuation

McKesson will invest $1.4 billion for a 49% minority stake in Option Care Health, under an agreement announced on October 6, 2026. The deal values Option Care at an enterprise value of $5.8 billion. Clayton, Dubilier & Rice will hold about 51%. Option Care will stay separately managed, while McKesson keeps a framework to acquire the remaining interest later, subject to conditions and regulatory approvals. In its first fiscal 2027 quarter, McKesson reported revenue of $105.38 billion, up 7.7% year on year, and adjusted earnings per share of $9.93. It will report second-quarter results on November 4, 2026.

TradingView
Oct 6th, 2026
CD&R and McKesson to acquire Option Care Health.

CD&R and McKesson to acquire Option Care Health. WASHINGTON (dpa-AFX) - CD&R, McKesson (MCK) and Option Care Health (OPCH) have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health for $32.05 per share, reflecting a total enterprise value of approximately $5.8 billion. Upon completion, Option Care Health will become a privately held company. CD&R will hold a majority interest of approximately 51% in Option Care Health and McKesson will invest approximately $1.4 billion for a minority interest of approximately 49%. The deal establishes a framework for McKesson's future acquisition of CD&R's interest in Option Care Health, subject to specified conditions and regulatory approvals. Option Care Health is an independent provider of home and alternate site infusion services. In pre-market trading on NasdaqGS, Option Care shares are up 20.50 percent to $28.16. For More Such Health News, visit rttnews.com. Copyright(c) 2026 RTTNews.com. All Rights Reserved Copyright RTT News/dpa-AFX Read the full article

McKesson Corporation
Oct 1st, 2026
McKesson wins Vizient's 2026 Distribution Excellence Award.

McKesson wins Vizient's 2026 Distribution Excellence Award. Vizient's 2026 Distribution Excellence Award honors suppliers that consistently deliver exceptional service and value to Vizient member health systems. September 29, 2026 In September 2026, Vizient presented McKesson with the 2026 Distribution Excellence Award at the Vizient Connections Summit in Las Vegas. The award recognizes suppliers that demonstrate superior service, support, reliability, ethics, and integrity in collaboration with Vizient.[1] Vizient, a member-owned healthcare performance improvement company, works with thousands of not-for-profit health systems and affiliates. Through its network, Vizient connects healthcare leaders with data, insights, and supplier relationships designed to drive value across the enterprise. For McKesson, the recognition reflects years of building a strategic, enterprise-wide relationship with Vizient and its member organizations at a time when health systems increasingly rely on collaborative partnerships to navigate complexity across pharmacy, supply chain, and clinical operations. Ali Cobb, Vice President of Health Systems National Accounts for McKesson Health Systems, has been central to strengthening collaboration and identifying new ways to support member needs. As workforce pressures, financial constraints, and supply chain challenges continue to shape healthcare, strong strategic partnerships remain critical to helping health systems build resilience and advance patient health. This award reflects a shared commitment by Vizient and McKesson to help health systems meet today's demands while preparing for what's next, together.